Status:
WITHDRAWN
Functional Microarray Augmentation of Skin Treatment With Lidocaine
Lead Sponsor:
University of Oklahoma
Conditions:
Pain Perception
Phlebotomy
Eligibility:
All Genders
18+ years
Phase:
PHASE2
PHASE3
Brief Summary
The purpose of this study is to determine whether co-application of a functional microarray of needles (FMA) speeds the rate at which topical anesthesia is provided. A secondary goal is to determine w...
Detailed Description
The study's primary goal is to determine whether co-application of a functional microarray of needles (FMA) speeds the rate at which topical anesthesia is provided by lidocaine gel 4% (LG4). A seconda...
Eligibility Criteria
Inclusion
- age at least 18 years, must provide voluntary consent, weight at least 50 kg, no allergies to lidocaine, no skin disease, inflammation, or infection at the venipuncture sites to be tested
Exclusion
- cannot have any major dermatologic disease history, known liver abnormalities, women who are currently breastfeeding
Key Trial Info
Start Date :
January 1 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2017
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT01145326
Start Date
January 1 2015
End Date
December 1 2017
Last Update
March 16 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Oklahoma Schusterman Clinic
Tulsa, Oklahoma, United States, 74135